MedTrace Logo

Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin

NCT03599999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2018-09-28

No results posted yet for this study

Summary

The Temocillin prescription frequency may be increased in order to reduce the use of carbapenems to reduce the progressive increase in carbapenem resistance observed in recent years. The investigators wish to study the responsibility of Temocillin in the occurrence of adverse effects in patients in the hospital of Amiens receiving a treatment containing this molecule.

Conditions

  • Bacterial Infection With One or More Extended Spectrum Betalactamases Remaining Susceptible to Temocillin

Interventions

DRUG

Adverse events detection

type of adverse events detected during treatment with Temocillin and imputed to Temocillin

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-24
Primary Completion
2017-12-29
Completion
2017-12-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03599999 on ClinicalTrials.gov